Early data suggest that metformin, a common diabetic drug, may significantly reduce the risk of severely shaped forms affecting thousands of pregnant people each year.
This form of illness – carnivorous excess (Hg), or overpackaging – can lead to complications during pregnancy, such as weight loss, dehydration, electrolyte imbalances, and long-term health issues for the mother and baby. It is also common for people who have an excessive pregnancy in their first pregnancy to experience it again in subsequent pregnancy.
Previous studies have established that low levels of a hormone called “growth and differentiation factor 15” (GDF15) before pregnancy often lead to genetically predisposed people often have lower hormones. During pregnancy, the placenta produces GDF15. This is beneficial for the survival and growth of the fetus. The theory that pre-pregnancy GDF15 is low, making individuals more sensitive due to the rapid rise in hormonals in pregnancy, causing extreme nausea and vomiting.
You might like it
Meanwhile, metformin, a drug commonly used to treat type 2 diabetes, is known to raise levels of GDF15 in all users, which is thought to reduce appetite and promote weight loss. Knowing this link to GDF15, researchers investigated whether metformin could “train” the body to withstand hormones before pregnancy.
Their research-based study, published in the American Journal of Obstetrics and Gynecology on June 27, showed that metformin reduces the risk of hypersynthesis by more than 70% when taken before pregnancy.
If confirmed through further research, Dr. Andrew Householder, an emergency physician who was not involved in the study, further noted that this approach to the issue would “be a game-changer.”
Related: We may finally understand how metformin lowers blood glucose levels, animal studies discover
“HG patients often change their family plans due to the severity of their illness in previous pregnancies,” the homeowner told Live Science in an email. “It makes a lot of sense to allow a person to have a normal pregnancy without severe symptoms or weight loss.”
For this study, the researchers recruited more than 5,400 participants who visited the Hyperemesis Gravidarum Education and Research Foundation social media platform. These people were asked to complete an online survey. Respondents reported daily use of 32 common substances, including prescribed and recreational medications, in each month prior to pregnancy, along with levels of nausea and vomiting during pregnancy.
Research suggests that pre-pregnancy use is associated with a 70% or more reduction in the risk of overdefecation in the first pregnancy and a 82% lower risk in the second pregnancy. Furthermore, pre-pregnancy cigarette use was associated with a 49% lower risk of experiencing excess sensation, but of course it increases the risk of other serious pregnancy complications.
In contrast, pre-pregnancy use of selective serotonin reuptake inhibitors (SSRIs), a common class of antidepressants, was associated with an increased risk of excessive inclusion in both the first and second pregnancies. Cannabis use was associated with increased risk only in the second pregnancy.
“A significant reduction in risk [tied to metformin] It provides strong evidence in support of pre-pregnancy metformin treatments that can provide benefits.
The findings are promising, but based on self-report data in highly selective populations, says Dr. Stephen O’Rahiley, professor of clinical biochemistry and medicine at the University of Cambridge, UK, who is not involved in the study. Olahilly has now needed clinical trials to see whether prescribing metformin before pregnancy could effectively prevent activeness.
Clinical trials also need to measure how metformin dose and timing affect it, Dr. Aimee Brecht-Doscher, an alumnus/Gyn doctor at Ventura County Medical Institution in California, told Live Science in an email.
Metformin is safe to take during pregnancy, and many users take it to treat diabetes during pregnancy, Brett Doscher pointed out. However, in particular, this study did not look at how the drug had an effect on morning illness at that time, or how many participants received postconcept medication.
For those who haven’t already taken metformin before pregnancy, when the drug is too late, it may help to stop excessive mixing. However, in theory, it can be used to prevent overpacking in subsequent pregnancy. But again, this should be confirmed in the exam.
“It’s likely that women who had HG have it once again,” Brecht Doscher said. “Many people have decided they will never get pregnant again because they have been hurt by experience. Using metformin to reduce the chances of recurrence could provide them with more options.”
“This study has shown it is worth pursuing, and it clears the path of clinical trials,” she added.
This article is for informational purposes only and is not intended to provide medical advice.
Source link
